Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $819.24 billion, total revenue of $166.46 billion and a weighted average PE ratio of 53.03.
Market Cap
819.24B
Revenue
166.46B
Profits
15.45B
PE Ratio
53.03
Profit Margin
9.28%
Dividend Yield
0.18%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 227.87B | -1.73% | 3,147,724 | 43.74B |
| 2 | DHR | Danaher Corporation | 165.99B | -0.24% | 2,533,894 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 56.89B | -0.30% | 542,741 | 4.17B |
| 4 | IQV | IQVIA Holdings Inc. | 41.42B | -0.45% | 1,894,466 | 15.90B |
| 5 | A | Agilent Technologies, Inc. | 41.32B | -1.39% | 1,728,931 | 6.95B |
| 6 | NTRA | Natera, Inc. | 33.14B | -5.83% | 2,059,596 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 29.93B | -0.39% | 163,378 | 3.94B |
| 8 | WAT | Waters Corporation | 23.61B | -0.69% | 440,664 | 3.11B |
| 9 | ILMN | Illumina, Inc. | 22.28B | -2.87% | 1,638,287 | 4.29B |
| 10 | LH | Labcorp Holdings Inc. | 21.11B | 0.37% | 719,620 | 13.77B |
| 11 | DGX | Quest Diagnostics Incorporated | 19.77B | -0.22% | 911,459 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.31B | 0.15% | 2,922,033 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.90B | -2.13% | 253,099 | 2.36B |
| 14 | ICLR | ICON Public Limited Company | 14.37B | -7.24% | 3,369,255 | 8.10B |
| 15 | GH | Guardant Health, Inc. | 14.01B | -1.08% | 1,799,782 | 902.57M |
| 16 | RVTY | Revvity, Inc. | 11.53B | -1.24% | 1,021,867 | 2.81B |
| 17 | CRL | Charles River Laboratories International, Inc. | 10.61B | -0.58% | 995,068 | 4.02B |
| 18 | QGEN | Qiagen N.V. | 9.98B | 2.41% | 1,184,645 | 2.07B |
| 19 | RDNT | RadNet, Inc. | 6.06B | 1.25% | 639,226 | 1.97B |
| 20 | SHC | Sotera Health Company | 5.34B | 0.05% | 1,407,464 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 4.01B | -2.07% | 160,974 | 254.14M |
| 22 | WGS | GeneDx Holdings Corp. | 3.97B | 0.67% | 295,219 | 402.19M |
| 23 | GRAL | GRAIL, Inc. | 3.82B | -5.36% | 938,813 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.44B | -3.44% | 569,218 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 2.12B | -4.95% | 1,593,225 | 376.57M |
| 26 | NEOG | Neogen Corporation | 2.11B | 31.57% | 22,996,919 | 880.32M |
| 27 | NEO | NeoGenomics, Inc. | 1.66B | 1.26% | 1,197,460 | 709.16M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.16B | -1.77% | 303,782 | 343.53M |
| 29 | OPK | OPKO Health, Inc. | 1.05B | 0.74% | 2,430,133 | 642.07M |
| 30 | CDNA | CareDx, Inc. | 885.67M | -8.89% | 1,126,276 | 358.00M |
| 31 | FLGT | Fulgent Genetics, Inc. | 862.15M | -0.43% | 235,264 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 743.74M | -10.43% | 1,639,342 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 611.48M | -1.06% | 832,807 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 281.88M | 1.58% | 221,410 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 251.94M | 4.65% | 22,903 | 75.75M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 214.98M | - | 26,668 | 4.40M |
| 37 | MDXH | MDxHealth SA | 161.86M | -2.10% | 68,023 | 103.07M |
| 38 | XGN | Exagen Inc. | 139.83M | 2.49% | 218,448 | 63.60M |
| 39 | FONR | FONAR Corporation | 121.59M | 0.11% | 83,841 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 44.39M | -6.38% | 63,288 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 40.45M | -0.78% | 5,109 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 21.69M | 4.35% | 335,112 | 513.02M |
| 43 | MYNZ | Mainz Biomed N.V. | 10.65M | -6.75% | 514,940 | 659.94K |
| 44 | MBAI | Check-Cap Ltd. | 10.24M | 1.74% | 17,950 | - |
| 45 | ADVB | Advanced Biomed Inc. | 7.67M | 0.97% | 13,610 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 5.79M | - | 22,960 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 5.39M | 1.31% | 4,230 | - |
| 48 | ISPC | iSpecimen Inc. | 3.21M | 2.96% | 806,307 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 2.65M | 0.63% | 87,247 | 29.52M |